Evidence map›Paper›PMID 30842994›Full record

ArticleJournal of Alzheimer's disease reports2019

A Novel Approach of Diffusion Tensor Visualization Based Neuro Fuzzy Classification System for Early Detection of Alzheimer's Disease.

Subrata Kar, D Dutta Majumder

Open access · diamondAbstract read
In one paragraph

Article in Journal of Alzheimer's disease reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Subrata KarDepartment of Mathematics, Dumkal Institute of Engineering & Technology, Murshidabad, West Bengal, India.
D Dutta MajumderDepartment of Electronics and Communication Sciences, Indian Statistical Institute, Kolkata, West Bengal, India.
Indian Statistical Institute · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study examined early detection of Alzheimer's disease (AD) by diffusion tensor visualization-based methodology and neuro-fuzzy tools. Initially, we proposed a model for the early detection of AD using the measurement of apparent diffusion coefficient, fractional anisotropy, and gray matter, which can determine neurological disorder patterns and abnormalities in brain white matter. These are used as input parameters into fuzzy tools, and using fuzzy rules, we evaluate the AD score as an output variable that provides a useful platform to physicians in determining the status of the disease. In the second stage, we present an investigative study on AD and used the neuro-fuzzy classification system for pattern recognition of either AD or healthy control. The experimental results are from 20 samples (14 for training, 3 for validation, and 3 for testing) used in an artificial neural network classification system. The neural network is trained with a training algorithm and the performance of the training algorithm is obtained by executing a fuzzy expert system. Out of 20 patients, 9 are AD patients and 11 are healthy control patients. We present a neuro-fuzzy tool as a better classifier for early detection of AD and obtain a satisfactory performance with 100% accuracy.

Indexed as

Alzheimer’s diseaseapparent diffusion coefficientdiffusion tensor imagingfractional anisotropygray matterneuro-fuzzy classification system

Identifiers

PMID30842994
PMCPMC6400114
OpenAlexW2906637289

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.